PolyCrystalLine is a prominent Contract Development and Manufacturing Organisation (CDMO) that has been providing reliable solutions for optimising and controlling the crystallisation process of Active Pharmaceutical Ingredients (APIs) since 2005. As a strategic partner, PolyCrystalLine is committed to exceeding client expectations, embracing a collaborative approach that goes beyond the traditional client-supplier relationship. The company’s innovative technologies, custom-made facilities, and highly skilled scientists ensure excellence in the development of new APIs and HPAPIs. Their mission is to support clients throughout drug development, minimising batch failures and crystallisation issues, while ensuring enhanced confidence in drug quality during manufacturing.

Services include:
– Contract Development and Manufacturing (CDMO)
– Contract Research
– Regulatory Services
– Containment
– Active Pharmaceutical Ingredients (APIs)
– Analytical Services

PolyCrystalLine’s integration of Contract Research Organisation (CRO) expertise with CDMO capabilities positions them as an outstanding partner for the production of intermediates and APIs in GMP compliance. For more information, please visit polycrystalline.it.